Katie Mills, MD
Ophthalmology · Goodlettsville, TNNPI 1376787630
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,650 of the $84,317 with a category attached, or 79.0%. AbbVie accounts for 93.6% of it on its own, with 20 other manufacturers making up the rest. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $351.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$79K
- Glaukos Corporation$3K
- Rxsight Inc$358
- Johnson & Johnson Surgical Vision, Inc.$319
- Tarsus Pharmaceuticals, Inc.$253
- Lensar, Inc.$241
- plus $885 from 15 others
What the payments were for
- Consulting fees$3,4634%
- Speaking & faculty fees$66,65079%
- Travel & lodging$8,11010%
- Food & beverage$6,0067%
- Education$430%
- Gifts$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 168 | $78,938 |
| Glaukos Corporation | 10 | $3,322 |
| Rxsight Inc | 2 | $358 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $319 |
| Tarsus Pharmaceuticals, Inc. | 8 | $253 |
| Lensar, Inc. | 6 | $241 |
| Bausch & Lomb Americas Inc. | 12 | $220 |
| Biotissue Holdings Inc. | 4 | $172 |
| Alcon | 7 | $168 |
| Oyster Point Pharma, Inc. | 2 | $48 |
| Dompe US, Inc. | 2 | $46 |
| Lombart Brothers, Inc. | 1 | $43 |
| Aerie Pharmaceuticals, Inc. | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Ocular Therapeutix, Inc. | 1 | $19 |
| Sight Sciences, Inc. | 1 | $18 |
| Omeros Corporation | 1 | $17 |
| NEW World Medical,inc. | 1 | $16 |
| Thea Pharma Inc. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DURYSTA$76,520
- Travoprost Intraocular Implant - iDose$1,350
- iStent inject W$1,000
- iDoseTR$251
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$246
- VERITAS Vision System$137
- RXSIGHT CONTACT LENS$113
- RXSIGHT INJECTOR CARTRIDGE$113
- RXSIGHT INJECTOR HANDPIECE$113
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$113
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$113
- Prokera$108
- AmnioGraft$108
How this compares
$84,317 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 114 | $56,291 |
| RestasisCyclosporine | 36 | $46,319 |
| XiidraLifitegrast | 28 | $42,500 |
| RocklatanNetarsudil Mesylat/Latanoprost | 66 | $30,114 |
| XdemvyLotilaner | 13 | $24,592 |
| CombiganBrimonidine Tartrate/Timolol | 53 | $22,065 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 52 | $11,616 |
| Travoprost | 46 | $10,603 |
| Latanoprost | 441 | $8,810 |
| Cyclosporine | 11 | $8,528 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 26 | $7,995 |
| VyzultaLatanoprostene Bunod | 17 | $7,314 |
| Bromfenac Sodium | 34 | $5,493 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 213 | $4,377 |
| RhopressaNetarsudil Mesylate | 14 | $4,372 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $78,938 | $124,675203 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $220 | $49,81445 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $35 | $34,48680 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $253 | $24,59213 claims |
| AlconSimbrinza | $168 | $7,99526 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $23 | $3,77411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Goodlettsville
- James LodenGoodlettsville$40K
- Amish PurohitGoodlettsville$35K
- Deborah ShermanNashville$3M
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian BiesmanNashville$630K
- Brian FowlerMemphis$206K
- Edward ChaumNashville$158K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.